We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.49B
AUM Growth
+$149M
Cap. Flow
-$38.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
20.52%
Holding
268
New
26
Increased
99
Reduced
104
Closed
25

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$19.9M
2
LITE icon
Lumentum
LITE
+$15.1M
3
VKTX icon
Viking Therapeutics
VKTX
+$13.8M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$12.7M
5
TREE icon
LendingTree
TREE
+$12M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$51.7M
2
SMCI icon
Super Micro Computer
SMCI
+$47.1M
3
CBAY
Cymabay Therapeutics
CBAY
+$25.2M
4
PRVA icon
Privia Health
PRVA
+$14M
5
SMPL icon
Simply Good Foods
SMPL
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 24.99%
3 Industrials 19.42%
4 Financials 9.95%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EE icon
251
Excelerate Energy
EE
$1.2B
– –
-198,224
Closed -$3.06M
HD icon
252
Home Depot
HD
$335B
– –
-905
Closed -$314K
HES
253
DELISTED
Hess
HES
– –
-1,398
Closed -$202K
ICUI icon
254
ICU Medical
ICUI
$4.04B
– –
-2,732
Closed -$272K
IPGP icon
255
IPG Photonics
IPGP
$3.81B
– –
-73,025
Closed -$7.93M
MNKD icon
256
MannKind Corp
MNKD
$1.22B
– –
-1,209,044
Closed -$4.4M
MRCY icon
257
Mercury Systems
MRCY
$6.23B
– –
-5,223
Closed -$191K
MURA
258
DELISTED
Mural Oncology
MURA
– –
-98
Closed -$580
NVST icon
259
Envista
NVST
$4.34B
– –
-20,143
Closed -$485K
ROKU icon
260
Roku
ROKU
$21.2B
– –
-250
Closed -$22.9K
SBAC icon
261
SBA Communications
SBAC
$18.3B
– –
-155
Closed -$39.4K
STE icon
262
Steris
STE
$21.3B
– –
-779
Closed -$171K
PRKS icon
263
United Parks & Resorts
PRKS
$2.12B
– –
-139,274
Closed -$7.36M
HRT
264
DELISTED
HireRight Holdings Corporation
HRT
– –
-251,401
Closed -$3.38M
CBAY
265
DELISTED
Cymabay Therapeutics
CBAY
– –
-1,068,661
Closed -$25.2M
KRTX
266
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-610
Closed -$193K
IMGN
267
DELISTED
Immunogen Inc
IMGN
– –
-1,744,981
Closed -$51.7M
SBNY
268
DELISTED
Signature Bank
SBNY
– –
-181
Closed -$290
7 8 9 10
11

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Emerald Advisers held 268 positions worth $2.49B, up 6.4% from $2.34B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q1 2024 filing shows 26 new, 99 increased, 104 reduced and 25 closed positions. Its largest new stake was Louisiana-Pacific: 276,306 shares worth $23.2M. The largest sale was Immunogen Inc, an estimated $51.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q1 2024 buy was Louisiana-Pacific: 276,306 shares worth $23.2M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2024, an estimated $12.7M increase.
  • Emerald Advisers's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $47.1M.
  • Emerald Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $51.7M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.49B portfolio in Q1 2024.
  • Emerald Advisers opened 26 new positions and closed 25 in Q1 2024.
  • Emerald Advisers's portfolio value rose 6.4% quarter-over-quarter to $2.49B.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.